Asset Allocation

As of March 31, 2026.
Type % Net
Cash 2.21%
Stock 93.50%
Bond 4.30%
Convertible 0.00%
Preferred 0.00%
Other 0.00%
View Asset Allocation
Start Trial

Market Capitalization

As of March 31, 2026
Large 77.29%
Mid 16.52%
Small 6.19%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 86.98%    % Emerging Markets: 13.02%    % Unidentified Markets: 0.00%

Americas 17.60%
16.78%
Canada 7.64%
United States 9.13%
0.82%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 50.74%
United Kingdom 15.29%
35.45%
Belgium 1.88%
Denmark 1.34%
France 9.16%
Germany 5.12%
Ireland 2.51%
Italy 1.35%
Netherlands 7.05%
Spain 1.27%
Switzerland 5.78%
0.00%
0.00%
Greater Asia 31.66%
Japan 9.23%
0.00%
10.98%
Hong Kong 2.03%
South Korea 1.35%
Taiwan 7.61%
11.45%
China 5.79%
India 5.66%
Unidentified Region 0.00%

Stock Sector Exposure

Cyclical
23.05%
Materials
1.90%
Consumer Discretionary
9.79%
Financials
11.37%
Real Estate
0.00%
Sensitive
48.88%
Communication Services
5.36%
Energy
2.57%
Industrials
22.46%
Information Technology
18.49%
Defensive
21.75%
Consumer Staples
3.60%
Health Care
16.81%
Utilities
1.34%
Not Classified
6.31%
Non Classified Equity
0.00%
Not Classified - Non Equity
6.31%
As of March 31, 2026
View Region Exposure
Start Trial

Stock Style Exposure

Large Cap Value --
Large Cap Core --
Large Cap Growth --
Mid Cap Value --
Mid Cap Core --
Mid Cap Growth --
Small Cap Value --
Small Cap Core --
Small Cap Growth --
No Data Available